LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 10

Search options

  1. Article ; Online: Early Treatment with Vigabatrin Does Not Decrease Focal Seizures or Improve Cognition in Tuberous Sclerosis Complex: The PREVeNT Trial.

    Bebin, Elizabeth Martina / Peters, Jurriaan M / Porter, Brenda E / McPherson, Tarrant O / O'Kelley, Sarah / Sahin, Mustafa / Taub, Katherine S / Rajaraman, Rajsekar / Randle, Stephanie C / McClintock, William M / Koenig, Mary Kay / Frost, Mike D / Northrup, Hope A / Werner, Klaus / Nolan, Danielle A / Wong, Michael / Krefting, Jessica L / Biasini, Fred / Peri, Kalyani /
    Cutter, Gary / Krueger, Darcy A

    Annals of neurology

    2023  

    Abstract: Objective: This study was undertaken to test the hypothesis that early vigabatrin treatment in tuberous sclerosis complex (TSC) infants improves neurocognitive outcome at 24 months of age.: Methods: A phase IIb multicenter randomized double-blind ... ...

    Abstract Objective: This study was undertaken to test the hypothesis that early vigabatrin treatment in tuberous sclerosis complex (TSC) infants improves neurocognitive outcome at 24 months of age.
    Methods: A phase IIb multicenter randomized double-blind placebo-controlled trial was conducted of vigabatrin at first epileptiform electroencephalogram (EEG) versus vigabatrin at seizure onset in infants with TSC. Primary outcome was Bayley Scales of Infant and Toddler Development, Third Edition (Bayley-III) cognitive assessment score at 24 months. Secondary outcomes were prevalence of drug-resistant epilepsy, additional developmental outcomes, and safety of vigabatrin.
    Results: Of 84 infants enrolled, 12 were screen failures, 4 went straight to open label vigabatrin, and 12 were not randomized (normal EEG throughout). Fifty-six were randomized to early vigabatrin (n = 29) or placebo (n = 27). Nineteen of 27 in the placebo arm transitioned to open label vigabatrin, with a median delay of 44 days after randomization. Bayley-III cognitive composite scores at 24 months were similar for participants randomized to vigabatrin or placebo. Additionally, no significant differences were found between groups in overall epilepsy incidence and drug-resistant epilepsy at 24 months, time to first seizure after randomization, and secondary developmental outcomes. Incidence of infantile spasms was lower and time to spasms after randomization was later in the vigabatrin group. Adverse events were similar across groups.
    Interpretation: Preventative treatment with vigabatrin based on EEG epileptiform activity prior to seizure onset does not improve neurocognitive outcome at 24 months in TSC children, nor does it delay onset or lower the incidence of focal seizures and drug-resistant epilepsy at 24 months. Preventative vigabatrin was associated with later time to onset and lower incidence of infantile spasms. ANN NEUROL 2023.
    Language English
    Publishing date 2023-08-28
    Publishing country United States
    Document type Journal Article
    ZDB-ID 80362-5
    ISSN 1531-8249 ; 0364-5134
    ISSN (online) 1531-8249
    ISSN 0364-5134
    DOI 10.1002/ana.26778
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: The chemical biology of protein phosphorylation.

    Tarrant, Mary Katherine / Cole, Philip A

    Annual review of biochemistry

    2009  Volume 78, Page(s) 797–825

    Abstract: The explosion of scientific interest in protein kinase-mediated signaling networks has led to the infusion of new chemical methods and their applications related to the analysis of phosphorylation pathways. We highlight some of these chemical biology ... ...

    Abstract The explosion of scientific interest in protein kinase-mediated signaling networks has led to the infusion of new chemical methods and their applications related to the analysis of phosphorylation pathways. We highlight some of these chemical biology approaches across three areas. First, we discuss the development of chemical tools to modulate the activity of protein kinases to explore kinase mechanisms and their contributions to phosphorylation events and cellular processes. Second, we describe chemical techniques developed in the past few years to dissect the structural and functional effects of phosphate modifications at specific sites in proteins. Third, we cover newly developed molecular imaging approaches to elucidate the spatiotemporal aspects of phosphorylation cascades in live cells. Exciting advances in our understanding of protein phosphorylation have been obtained with these chemical biology approaches, but continuing opportunities for technological innovation remain.
    MeSH term(s) Animals ; Humans ; Phosphorylation ; Protein Kinases/chemistry ; Protein Kinases/metabolism ; Proteins/chemistry ; Proteins/metabolism ; Signal Transduction
    Chemical Substances Proteins ; Protein Kinases (EC 2.7.-)
    Language English
    Publishing date 2009-06-02
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 207924-0
    ISSN 1545-4509 ; 0066-4154
    ISSN (online) 1545-4509
    ISSN 0066-4154
    DOI 10.1146/annurev.biochem.78.070907.103047
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Design and implementation of a digital site-less clinical study of serial rapid antigen testing to identify asymptomatic SARS-CoV-2 infection.

    Soni, Apurv / Herbert, Carly / Pretz, Caitlin / Stamegna, Pamela / Filippaios, Andreas / Shi, Qiming / Suvarna, Thejas / Harman, Emma / Schrader, Summer / Nowak, Chris / Schramm, Eric / Kheterpal, Vik / Behar, Stephanie / Tarrant, Seanan / Ferranto, Julia / Hafer, Nathaniel / Robinson, Matthew / Achenbach, Chad / Murphy, Robert L /
    Manabe, Yukari C / Gibson, Laura / Barton, Bruce / O'Connor, Laurel / Fahey, Nisha / Orvek, Elizabeth / Lazar, Peter / Ayturk, Didem / Wong, Steven / Zai, Adrian / Cashman, Lisa / Rao, Lokinendi V / Luzuriaga, Katherine / Lemon, Stephenie / Blodgett, Allison / Trippe, Elizabeth / Barcus, Mary / Goldberg, Brittany / Roth, Kristian / Stenzel, Timothy / Heetderks, William / Broach, John / McManus, David

    Journal of clinical and translational science

    2023  Volume 7, Issue 1, Page(s) e120

    Abstract: Background: Rapid antigen detection tests (Ag-RDT) for SARS-CoV-2 with emergency use authorization generally include a condition of authorization to evaluate the test's performance in asymptomatic individuals when used serially. We aim to describe a ... ...

    Abstract Background: Rapid antigen detection tests (Ag-RDT) for SARS-CoV-2 with emergency use authorization generally include a condition of authorization to evaluate the test's performance in asymptomatic individuals when used serially. We aim to describe a novel study design that was used to generate regulatory-quality data to evaluate the serial use of Ag-RDT in detecting SARS-CoV-2 virus among asymptomatic individuals.
    Methods: This prospective cohort study used a siteless, digital approach to assess longitudinal performance of Ag-RDT. Individuals over 2 years old from across the USA with no reported COVID-19 symptoms in the 14 days prior to study enrollment were eligible to enroll in this study. Participants throughout the mainland USA were enrolled through a digital platform between October 18, 2021 and February 15, 2022. Participants were asked to test using Ag-RDT and molecular comparators every 48 hours for 15 days. Enrollment demographics, geographic distribution, and SARS-CoV-2 infection rates are reported.
    Key results: A total of 7361 participants enrolled in the study, and 492 participants tested positive for SARS-CoV-2, including 154 who were asymptomatic and tested negative to start the study. This exceeded the initial enrollment goals of 60 positive participants. We enrolled participants from 44 US states, and geographic distribution of participants shifted in accordance with the changing COVID-19 prevalence nationwide.
    Conclusions: The digital site-less approach employed in the "Test Us At Home" study enabled rapid, efficient, and rigorous evaluation of rapid diagnostics for COVID-19 and can be adapted across research disciplines to optimize study enrollment and accessibility.
    Language English
    Publishing date 2023-05-10
    Publishing country England
    Document type Journal Article
    ISSN 2059-8661
    ISSN (online) 2059-8661
    DOI 10.1017/cts.2023.540
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Protein phosphorylation by semisynthesis: from paper to practice.

    Szewczuk, Lawrence M / Tarrant, Mary Katherine / Cole, Philip A

    Methods in enzymology

    2009  Volume 462, Page(s) 1–24

    Abstract: Deconvolution of specific phosphorylation events can be complicated by the reversibility of modification. Protein semisynthesis with phosphonate analogues offers an attractive approach to functional analysis of signaling pathways. In this technique, N- ... ...

    Abstract Deconvolution of specific phosphorylation events can be complicated by the reversibility of modification. Protein semisynthesis with phosphonate analogues offers an attractive approach to functional analysis of signaling pathways. In this technique, N- and C-terminal synthetic peptides containing nonhydrolyzable phosphonates at target residues can be ligated to recombinant proteins of interest. The resultant semisynthetic proteins contain site specific, stoichiometric phosphonate modifications and are completely resistant to phosphatases. Control of stoichiometry, specificity, and reversibility allows for complex signaling systems to be broken down into individual events and discretely examined. This chapter outlines the general methods and considerations for designing and carrying out phosphoprotein semisynthetic projects.
    MeSH term(s) Alanine/analogs & derivatives ; Alanine/chemistry ; Animals ; Humans ; Inteins ; Organophosphonates/chemical synthesis ; Organophosphonates/chemistry ; Phenylalanine/analogs & derivatives ; Phenylalanine/chemistry ; Phosphoamino Acids/chemistry ; Phosphopeptides/chemical synthesis ; Phosphoproteins/chemistry ; Phosphoproteins/metabolism ; Phosphorylation ; Phosphoserine/analogs & derivatives ; Phosphoserine/chemistry ; Phosphothreonine/analogs & derivatives ; Phosphothreonine/chemistry ; Recombinant Fusion Proteins/chemistry ; Recombinant Fusion Proteins/metabolism
    Chemical Substances Organophosphonates ; Phosphoamino Acids ; Phosphopeptides ; Phosphoproteins ; Recombinant Fusion Proteins ; phosphonodifluoromethylene alanine ; phosphonodifluoromethylphenylalanine ; Phosphothreonine (1114-81-4) ; Phosphoserine (17885-08-4) ; Phenylalanine (47E5O17Y3R) ; Alanine (OF5P57N2ZX)
    Language English
    Publishing date 2009-07-24
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ISSN 1557-7988
    ISSN (online) 1557-7988
    DOI 10.1016/S0076-6879(09)62001-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Finding a Needle in a Haystack: Design and Implementation of a Digital Site-less Clinical Study of Serial Rapid Antigen Testing to Identify Asymptomatic SARS-CoV-2 Infection.

    Soni, Apurv / Herbert, Carly / Pretz, Caitlin / Stamegna, Pamela / Filippaios, Andreas / Shi, Qiming / Suvarna, Thejas / Harman, Emma / Schrader, Summer / Nowak, Chris / Schramm, Eric / Kheterpal, Vik / Behar, Stephanie / Tarrant, Seanan / Ferranto, Julia / Hafer, Nathaniel / Robinson, Matthew / Achenbach, Chad / Murphy, Robert L /
    Manabe, Yukari C / Gibson, Laura / Barton, Bruce / O'Connor, Laurel / Fahey, Nisha / Orvek, Elizabeth / Lazar, Peter / Ayturk, Didem / Wong, Steven / Zai, Adrian / Cashman, Lisa / Rao, Lokinendi V / Luzuriaga, Katherine / Lemon, Stephenie / Blodgett, Allison / Trippe, Elizabeth / Barcus, Mary / Goldberg, Brittany / Roth, Kristian / Stenzel, Timothy / Heetderks, William / Broach, John / McManus, David

    medRxiv : the preprint server for health sciences

    2023  

    Abstract: Background: Rapid antigen tests (Ag-RDT) for SARS-CoV-2 with Emergency Use Authorization generally include a condition of authorization to evaluate the test's performance in asymptomatic individuals when used serially.: Objective: To describe a novel ...

    Abstract Background: Rapid antigen tests (Ag-RDT) for SARS-CoV-2 with Emergency Use Authorization generally include a condition of authorization to evaluate the test's performance in asymptomatic individuals when used serially.
    Objective: To describe a novel study design to generate regulatory-quality data to evaluate serial use of Ag-RDT in detecting SARS-CoV-2 virus among asymptomatic individuals.
    Design: Prospective cohort study using a decentralized approach. Participants were asked to test using Ag-RDT and molecular comparators every 48 hours for 15 days.
    Setting: Participants throughout the mainland United States were enrolled through a digital platform between October 18, 2021 and February 15, 2022. Ag-RDTs were completed at home, and molecular comparators were shipped to a central laboratory.
    Participants: Individuals over 2 years old from across the U.S. with no reported COVID-19 symptoms in the 14 days prior to study enrollment were eligible to enroll in this study.
    Measurements: Enrollment demographics, geographic distribution, and SARS-CoV-2 infection rates are reported.
    Key results: A total of 7,361 participants enrolled in the study, and 492 participants tested positive for SARS-CoV-2, including 154 who were asymptomatic and tested negative to start the study. This exceeded the initial enrollment goals of 60 positive participants. We enrolled participants from 44 U.S. states, and geographic distribution of participants shifted in accordance with the changing COVID-19 prevalence nationwide.
    Limitations: New, complex workflows required significant operational and data team support. Conclusions: The digital site-less approach employed in the 'Test Us At Home' study enabled rapid, efficient, and rigorous evaluation of rapid diagnostics for COVID-19, and can be adapted across research disciplines to optimize study enrollment and accessibility.
    Language English
    Publishing date 2023-01-23
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2022.08.04.22278274
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Design and implementation of a digital site-less clinical study of serial rapid antigen testing to identify asymptomatic SARS-CoV-2 infection

    Apurv Soni / Carly Herbert / Caitlin Pretz / Pamela Stamegna / Andreas Filippaios / Qiming Shi / Thejas Suvarna / Emma Harman / Summer Schrader / Chris Nowak / Eric Schramm / Vik Kheterpal / Stephanie Behar / Seanan Tarrant / Julia Ferranto / Nathaniel Hafer / Matthew Robinson / Chad Achenbach / Robert L. Murphy /
    Yukari C. Manabe / Laura Gibson / Bruce Barton / Laurel O’Connor / Nisha Fahey / Elizabeth Orvek / Peter Lazar / Didem Ayturk / Steven Wong / Adrian Zai / Lisa Cashman / Lokinendi V. Rao / Katherine Luzuriaga / Stephenie Lemon / Allison Blodgett / Elizabeth Trippe / Mary Barcus / Brittany Goldberg / Kristian Roth / Timothy Stenzel / William Heetderks / John Broach / David McManus

    Journal of Clinical and Translational Science, Vol

    2023  Volume 7

    Abstract: Abstract Background: Rapid antigen detection tests (Ag-RDT) for SARS-CoV-2 with emergency use authorization generally include a condition of authorization to evaluate the test’s performance in asymptomatic individuals when used serially. We aim to ... ...

    Abstract Abstract Background: Rapid antigen detection tests (Ag-RDT) for SARS-CoV-2 with emergency use authorization generally include a condition of authorization to evaluate the test’s performance in asymptomatic individuals when used serially. We aim to describe a novel study design that was used to generate regulatory-quality data to evaluate the serial use of Ag-RDT in detecting SARS-CoV-2 virus among asymptomatic individuals. Methods:This prospective cohort study used a siteless, digital approach to assess longitudinal performance of Ag-RDT. Individuals over 2 years old from across the USA with no reported COVID-19 symptoms in the 14 days prior to study enrollment were eligible to enroll in this study. Participants throughout the mainland USA were enrolled through a digital platform between October 18, 2021 and February 15, 2022. Participants were asked to test using Ag-RDT and molecular comparators every 48 hours for 15 days. Enrollment demographics, geographic distribution, and SARS-CoV-2 infection rates are reported. Key Results:A total of 7361 participants enrolled in the study, and 492 participants tested positive for SARS-CoV-2, including 154 who were asymptomatic and tested negative to start the study. This exceeded the initial enrollment goals of 60 positive participants. We enrolled participants from 44 US states, and geographic distribution of participants shifted in accordance with the changing COVID-19 prevalence nationwide. Conclusions:The digital site-less approach employed in the “Test Us At Home” study enabled rapid, efficient, and rigorous evaluation of rapid diagnostics for COVID-19 and can be adapted across research disciplines to optimize study enrollment and accessibility.
    Keywords Covid-19 ; study recruitment ; digital trial ; rapid antigen tests ; point-of-care diagnostics ; Medicine ; R
    Subject code 150
    Language English
    Publishing date 2023-01-01T00:00:00Z
    Publisher Cambridge University Press
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article ; Online: Mechanistic insights into the activation of oncogenic forms of EGF receptor.

    Wang, Zhihong / Longo, Patti A / Tarrant, Mary Katherine / Kim, Kwangsoo / Head, Sarah / Leahy, Daniel J / Cole, Philip A

    Nature structural & molecular biology

    2011  Volume 18, Issue 12, Page(s) 1388–1393

    Abstract: Epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase that is commonly activated by mutation in non-small cell lung cancer. The mechanism of this oncogenic activation is not completely understood, but in contrast to that of the wild-type ... ...

    Abstract Epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase that is commonly activated by mutation in non-small cell lung cancer. The mechanism of this oncogenic activation is not completely understood, but in contrast to that of the wild-type EGFR, it is proposed to be independent of kinase domain dimerization. Mechanistic studies on EGFR have mainly relied on cell-based assays or isolated kinase domain measurements. Here we show, using purified, near full-length human EGFR proteins (tEGFRs), that two oncogenic mutants are fully active independently of EGF and highly resistant to the therapeutic and endogenous inhibitors cetuximab, lapatinib and MIG6. Based on the pattern of inhibition and the effects of additional asymmetric kinase dimer interface mutations, we propose that these oncogenic EGFR mutants drive and strongly depend on the formation of the asymmetric kinase dimer for activation, which has implications for drug design and cancer treatment strategies.
    MeSH term(s) Antibodies, Monoclonal/pharmacology ; Antibodies, Monoclonal, Humanized ; Cetuximab ; Epidermal Growth Factor/metabolism ; ErbB Receptors/antagonists & inhibitors ; ErbB Receptors/chemistry ; ErbB Receptors/genetics ; HEK293 Cells ; Humans ; Kinetics ; Lapatinib ; Lung Neoplasms/genetics ; Models, Molecular ; Mutation ; Quinazolines/pharmacology ; Tumor Suppressor Proteins/chemistry
    Chemical Substances Antibodies, Monoclonal ; Antibodies, Monoclonal, Humanized ; Quinazolines ; Tumor Suppressor Proteins ; Lapatinib (0VUA21238F) ; Epidermal Growth Factor (62229-50-9) ; EGFR protein, human (EC 2.7.10.1) ; ErbB Receptors (EC 2.7.10.1) ; Cetuximab (PQX0D8J21J)
    Language English
    Publishing date 2011-11-20
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2126708-X
    ISSN 1545-9985 ; 1545-9993
    ISSN (online) 1545-9985
    ISSN 1545-9993
    DOI 10.1038/nsmb.2168
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Site-specific introduction of an acetyl-lysine mimic into peptides and proteins by cysteine alkylation.

    Huang, Rong / Holbert, Marc A / Tarrant, Mary Katherine / Curtet, Sandrine / Colquhoun, David R / Dancy, Beverley M / Dancy, Blair C / Hwang, Yousang / Tang, Yong / Meeth, Katrina / Marmorstein, Ronen / Cole, Robert N / Khochbin, Saadi / Cole, Philip A

    Journal of the American Chemical Society

    2010  Volume 132, Issue 29, Page(s) 9986–9987

    Abstract: Protein acetylation on Lys residues is recognized as a significant post-translational modification in cells, but it is often difficult to discern the direct structural and functional effects of individual acetylation events. Here we describe a new tool, ... ...

    Abstract Protein acetylation on Lys residues is recognized as a significant post-translational modification in cells, but it is often difficult to discern the direct structural and functional effects of individual acetylation events. Here we describe a new tool, methylthiocarbonyl-aziridine, to install acetyl-Lys mimics site-specifically into peptides and proteins by alkylation of Cys residues. We demonstrate that the resultant thiocarbamate modification can be recognized by the Brdt bromodomain and site-specific antiacetyl-Lys antibodies, is resistant to histone deacetylase cleavage, and can confer activation of the histone acetyltransferase Rtt109 by simulating autoacetylation. We also use this approach to obtain functional evidence that acetylation of CK2 protein kinase on Lys102 can stimulate its catalytic activity.
    MeSH term(s) Acetylation ; Alkylation ; Animals ; Aziridines/chemistry ; Aziridines/metabolism ; Binding Sites ; Biomimetic Materials/chemistry ; Biomimetic Materials/metabolism ; Cysteine/metabolism ; Histones/chemistry ; Histones/metabolism ; Lysine/metabolism ; Peptides/chemistry ; Peptides/metabolism ; Proteins/chemistry ; Proteins/metabolism ; Substrate Specificity
    Chemical Substances Aziridines ; Histones ; Peptides ; Proteins ; aziridine (54P5FEX9FH) ; Lysine (K3Z4F929H6) ; Cysteine (K848JZ4886)
    Language English
    Publishing date 2010-07-06
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 3155-0
    ISSN 1520-5126 ; 0002-7863
    ISSN (online) 1520-5126
    ISSN 0002-7863
    DOI 10.1021/ja103954u
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Seven features of safety in maternity units: a framework based on multisite ethnography and stakeholder consultation.

    Liberati, Elisa Giulia / Tarrant, Carolyn / Willars, Janet / Draycott, Tim / Winter, Cathy / Kuberska, Karolina / Paton, Alexis / Marjanovic, Sonja / Leach, Brandi / Lichten, Catherine / Hocking, Lucy / Ball, Sarah / Dixon-Woods, Mary

    BMJ quality & safety

    2020  Volume 30, Issue 6, Page(s) 444–456

    Abstract: Background: Reducing avoidable harm in maternity services is a priority globally. As well as learning from mistakes, it is important to produce rigorous descriptions of 'what good looks like'.: Objective: We aimed to characterise features of safety ... ...

    Abstract Background: Reducing avoidable harm in maternity services is a priority globally. As well as learning from mistakes, it is important to produce rigorous descriptions of 'what good looks like'.
    Objective: We aimed to characterise features of safety in maternity units and to generate a plain language framework that could be used to guide learning and improvement.
    Methods: We conducted a multisite ethnography involving 401 hours of non-participant observations 33 semistructured interviews with staff across six maternity units, and a stakeholder consultation involving 65 semistructured telephone interviews and one focus group.
    Results: We identified seven features of safety in maternity units and summarised them into a framework, named
    Conclusions: This large qualitative study has enabled the generation of a new plain language framework-For Us-that identifies the behaviours and practices that appear to be features of safe care in hospital-based maternity units.
    MeSH term(s) Anthropology, Cultural ; Female ; Focus Groups ; Humans ; Pregnancy ; Qualitative Research ; Referral and Consultation
    Language English
    Publishing date 2020-09-25
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2592909-4
    ISSN 2044-5423 ; 2044-5415
    ISSN (online) 2044-5423
    ISSN 2044-5415
    DOI 10.1136/bmjqs-2020-010988
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Regulation of CK2 by phosphorylation and O-GlcNAcylation revealed by semisynthesis.

    Tarrant, Mary Katherine / Rho, Hee-Sool / Xie, Zhi / Jiang, Yu Lin / Gross, Christopher / Culhane, Jeffrey C / Yan, Gai / Qian, Jiang / Ichikawa, Yoshitaka / Matsuoka, Tatsuji / Zachara, Natasha / Etzkorn, Felicia A / Hart, Gerald W / Jeong, Jun Seop / Blackshaw, Seth / Zhu, Heng / Cole, Philip A

    Nature chemical biology

    2012  Volume 8, Issue 3, Page(s) 262–269

    Abstract: Protein serine-threonine kinase casein kinase II (CK2) is involved in a myriad of cellular processes including cell growth and proliferation through its phosphorylation of hundreds of substrates, yet how CK2 function is regulated is poorly understood. ... ...

    Abstract Protein serine-threonine kinase casein kinase II (CK2) is involved in a myriad of cellular processes including cell growth and proliferation through its phosphorylation of hundreds of substrates, yet how CK2 function is regulated is poorly understood. Here we report that the CK2 catalytic subunit CK2α is modified by O-linked β-N-acetyl-glucosamine (O-GlcNAc) on Ser347, proximal to a cyclin-dependent kinase phosphorylation site (Thr344). We use protein semisynthesis to show that phosphorylation of Thr344 increases the cellular stability of CK2α by strengthening its interaction with Pin1, whereas glycosylation of Ser347 seems to be antagonistic to Thr344 phosphorylation and permissive to proteasomal degradation. By performing kinase assays with site-specifically phospho- and glyco-modified CK2α in combination with CK2β and Pin1 binding partners on human protein microarrays, we show that the kinase substrate selectivity of CK2 is modulated by these specific post-translational modifications. This study suggests how a promiscuous protein kinase can be regulated at multiple levels to achieve particular biological outputs.
    MeSH term(s) Acetylglucosamine/metabolism ; Animals ; Casein Kinase II/biosynthesis ; Casein Kinase II/chemistry ; Casein Kinase II/metabolism ; Cell Line ; Humans ; NIMA-Interacting Peptidylprolyl Isomerase ; Peptidylprolyl Isomerase/chemistry ; Peptidylprolyl Isomerase/metabolism ; Phosphorylation ; Rats ; Serine/metabolism
    Chemical Substances NIMA-Interacting Peptidylprolyl Isomerase ; Serine (452VLY9402) ; Casein Kinase II (EC 2.7.11.1) ; PIN1 protein, human (EC 5.2.1.8) ; Peptidylprolyl Isomerase (EC 5.2.1.8) ; Acetylglucosamine (V956696549)
    Language English
    Publishing date 2012-01-22
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2202962-X
    ISSN 1552-4469 ; 1552-4450
    ISSN (online) 1552-4469
    ISSN 1552-4450
    DOI 10.1038/nchembio.771
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top